|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/541 | (2006.01) |
| A61P 29/00 | (2006.01) | ||
| A61K 9/20 | (2006.01) |
| (11) | Number of the document | 3595667 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18713553.8 |
| Date of filing the European patent application | 2018-03-12 | |
| (97) | Date of publication of the European application | 2020-01-22 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-20 |
| (46) | Date of publication of the claims translation | 2024-01-25 |
| (86) | Number | PCT/US2018/022027 |
| Date | 2018-03-12 |
| (87) | Number | WO 2018/169875 |
| Date | 2018-09-20 |
| (30) | Number | Date | Country code |
| 201762471171 P | 2017-03-14 | US | |
| 201762536614 P | 2017-07-25 | US |
| (72) |
ALONZO, David , US
LI, Bei , US
STEFANIDIS, Dimitrios , US
|
| (73) |
Alfasigma S.p.A. ,
Via Ragazzi del '99, 5, 40133 Bologna,
IT
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmacinė kompozicija, apimanti JAK inhibitorių |
| PHARMACEUTICAL COMPOSITIONS COMPRISING A JAK INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2025-01-21 | 8 | 185.00 EUR |
| 2026-03-12 |